doi.org/10.1038/sj.leu.2402751, hdl.handle.net/1765/52780
Leukemia
Department of Immunology

Moopett, J., van der Velden, V., Wijkhuijs, A., Hancock, J., van Dongen, J., & Gouden, N. (2003). Inhibition affecting RQ-PCR-based assessment of minimal residual disease in acute lymphoblastic leukemia: Reversal by addition of bovine serum albumin [2]. Leukemia, 17(1), 268–270. doi:10.1038/sj.leu.2402751